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Endoplasmic reticulum (ER) stress and inflammation are important mechanisms that
underlie many of the serious consequences of type II diabetes. However, the role of
ER stress and inflammation in impaired ischaemia-induced neovascularization in type
II diabetes is unknown. We studied ischaemia-induced neovascularization in the hind-
limb of 4-week-old db - /db- mice and their controls treated with or without the ER
stress inhibitor (tauroursodeoxycholic acid, TUDCA, 150 mg/kg per day) and
interleukin-1 receptor antagonist (anakinra, 0.5 microg/mouse per day) for 4 weeks.
Blood pressure was similar in all groups of mice. Blood glucose, insulin levels, and
body weight were reduced in db - /db- mice treated with TUDCA. Increased
cholesterol and reduced adiponectin in db - /db- mice were restored by TUDCA and
anakinra treatment. ER stress and inflammation in the ischaemic hind-limb in db - /db-
mice were attenuated by TUDCA and anakinra treatment. Ischaemia-induced
neovascularization and blood flow recovery were significantly reduced in db - /db-
mice compared to control. Interestingly, neovascularization and blood flow recovery
were restored in db - /db- mice treated with TUDCA or anakinra compared to non-
treated db - /db- mice. TUDCA and anakinra enhanced eNOS-cGMP, VEGFR2, and
reduced ERK1/2 MAP-kinase signalling, while endothelial progenitor cell number was
similar in all groups of mice. Our findings demonstrate that the inhibition of ER stress
and inflammation prevents impaired ischaemia-induced neovascularization in type II
diabetic mice. Thus, ER stress and inflammation could be potential targets for a novel
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